Liver Disease

Gastroenterology·MeSH: Liver Diseases

38 drugs in development·22 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Drug	Company
avatrombopag	GYRE THERAPEUTICS, INC. (GYRE) Analyze with AI →
contiva	GYRE THERAPEUTICS, INC. (GYRE) Analyze with AI →
doptelet	AKORN INC (AKRX) Analyze with AI →

Phase 3(5)

Drug	Company
100 mg resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL) Analyze with AI →
Fazirsiran	ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Analyze with AI →
maralixibat	Mirum Pharmaceuticals, Inc. (MIRM) Analyze with AI →
Pegozafermin	89bio, Inc. (ETNB) Analyze with AI →
Resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL) Analyze with AI →

Phase 2(9)

Drug	Company
cagrilintide + semaglutide	Novo Nordisk A/S (NVO) Analyze with AI →
Cholates	Mirum Pharmaceuticals, Inc. (MIRM) Analyze with AI →
GSK-4532990	ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Analyze with AI →
pemvidutide	Altimmune, Inc. (ALT) Analyze with AI →
pemvidutide (ALT-801)	Altimmune, Inc. (ALT) Analyze with AI →
pemvidutide (formerly ALT-801)	Altimmune, Inc. (ALT) Analyze with AI →
rencofilstat (formerly CRV431)	Hepion Pharmaceuticals, Inc. (CTRVP) Analyze with AI →
tesamorelin	IO Biotech, Inc. (IOBT) Analyze with AI →
tvb-2640	Sagimet Biosciences Inc. (SGMT) Analyze with AI →

Phase 1(6)

Drug	Company
aln-cideb	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →
etavopivat	Novo Nordisk A/S (NVO) Analyze with AI →
nnc0194-0499	Novo Nordisk A/S (NVO) Analyze with AI →
nnc0560-0004	Novo Nordisk A/S (NVO) Analyze with AI →
nnc4005-001	Novo Nordisk A/S (NVO) Analyze with AI →
SER-147	Seres Therapeutics, Inc. (MCRB) Analyze with AI →

Preclinical(8)

Drug	Company
a2342	ALBIREO PHARMA, INC. (ALBO) Analyze with AI →
a3907	ALBIREO PHARMA, INC. (ALBO) Analyze with AI →
agtx-2003	Agentix Corp. (AGTX) Analyze with AI →
AGTX-2003 (RTI-1092769)	Agentix Corp. (AGTX) Analyze with AI →
aln1003	Alaunos Therapeutics, Inc. (TCRT) Analyze with AI →
electroceuticals therapeutic devices	ENDONOVO THERAPEUTICS, INC. (ENDV) Analyze with AI →
jkb-122	Biostax Corp. (BTAX) Analyze with AI →
siRNA targeting Beta2-spectrin	Bullfrog AI Holdings Inc. (BFRG) Analyze with AI →

Unknown(4)

Drug	Company
Heptral™	ABBOTT LABORATORIES (ABT) Analyze with AI →
legalon	Mylan II B.V. (MYL) Analyze with AI →
Samyr™	ABBOTT LABORATORIES (ABT) Analyze with AI →
Transmetil™	ABBOTT LABORATORIES (ABT) Analyze with AI →

Phase 1/Phase 2(2)

Drug	Company
aln-pnp	REGENERON PHARMACEUTICALS, INC. (REGN) Analyze with AI →
WVE-008	Wave Life Sciences Ltd. (WVE) Analyze with AI →

Phase 4(1)

Drug	Company
LIVMARLI (maralixibat)	Mirum Pharmaceuticals, Inc. (MIRM) Analyze with AI →

BioSniper tracks 38 drugs in development for Liver Disease across 22 companies.

There are 1 clinical trial targeting Liver Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.